scholarly journals Self-correction of pathologic tooth migration after nonsurgical periodontal treatment in a metabolic syndrome patient with severe periodontitis and drug-influenced gingival enlargement

2021 ◽  
Vol 25 (4) ◽  
pp. 350
Author(s):  
Kuo Yuan ◽  
Hsin-Che Lee ◽  
Chao-Nan Wu
Keyword(s):  
Metabolic Syndrome ◽  
Periodontal Treatment ◽  
Syndrome Patient ◽  
Metabolic Syndrome Patient ◽  
Severe Periodontitis ◽  
Gingival Enlargement ◽  
Tooth Migration

Impact of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a randomized clinical trial

2020 ◽  
Author(s):  
Eduardo Montero ◽  
Mercedes López ◽  
Honorato Vidal ◽  
María Martínez ◽  
Jorge Marrero ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Clinical Trial ◽  
Periodontal Therapy ◽  
Periodontal Treatment ◽  
Markers Of Inflammation ◽  
Severe Periodontitis ◽  
Secondary Outcomes ◽  
Hs Crp ◽  
The Impact

Abstract Background Although there is evidence of positive effect of periodontal therapy on systemic inflammation, this response is highly variable among subjects. It was the aim of this clinical investigation to determine the impact of periodontal treatment on systemic markers of inflammation in patients with metabolic syndrome (MetS) and periodontitis. Methods In this parallel-arm, double blind, randomized controlled clinical trial, 63 patients with MetS and severe periodontitis were randomly assigned to receive intensive periodontal treatment (IPT; scaling and root planing plus azithromycin 500 mg, q.d., for three days) or minimal periodontal treatment (MPT; supragingival professional mechanical plaque removal plus a placebo). The primary outcome was the impact of the tested interventions on hs-CRP serum levels at 6 months. As secondary outcomes, differences in the levels of cytokines, markers of prothrombotic states, carbohydrate and lipids metabolism, as well as blood pressure, were measured at 3 and 6 months after therapy. Results The ITT population consisted on 63 subjects randomly assigned to either MPT (n = 31) or IPT (n = 32) groups. At baseline, mean hs-CRP was 3.9 mg/L (standard deviation, SD = 2.9) and 3.9 mg/L (SD = 3.4), respectively, and no significant differences in their cardiometabolic risk profiles were detected between groups. After 6 months, unadjusted mean hs-CRP were 2.9 mg/L (standard error, SE = 0.4) and 4.0 (SE = 0.8), respectively. Adjusting for baseline hs-CRP, sex, age, smoking status and body mass index, hs-CRP was 1.2 mg/L (95% confidence interval, [CI 0.4; 2.0]; p = 0.004) lower in the IPT group than in the MPT group. In the secondary outcomes, significant reductions in IL-1β, TNF-α, HbA1c and blood pressure were observed in the IPT group at 3 months, when compared to the MPT group. Conclusion Effective periodontal treatment significantly reduced hs-CRP after 6 months in patients with MetS and severe periodontitis. Periodontal therapy might be useful to reduce cardiovascular risk in these patients. Trial registration: ClinicalTrials.gov Registration Number: NCT03960216.

scholarly journals Metabolic syndrome patient compliance with drug treatment

Clinics ◽  
2008 ◽  
Vol 63 (5) ◽  
Author(s):  
Nilcéia Lopes ◽  
Antonio Carlos Zanini ◽  
Antonio Casella-Filho ◽  
Antonio Carlos Palandri Chagas
Keyword(s):  
Metabolic Syndrome ◽  
Drug Treatment ◽  
Patient Compliance ◽  
Syndrome Patient ◽  
Metabolic Syndrome Patient

scholarly journals Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension

2009 ◽  
Vol 6 (1) ◽  
pp. 64-66
Author(s):  
K P Ivanov ◽  
Viktoriya Borisovna Mychka ◽  
M Yu Kirillova ◽  
Irina Evgen'evna Chazova ◽  
K P Ivanov ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Arterial Hypertension ◽  
Clinical Case ◽  
Syndrome Patient ◽  
The Metabolic Syndrome ◽  
Metabolic Syndrome Patient

scholarly journals Potential of Turmeric (Curcuma Longa) in Increasing Hemoglobin Levels: Systematic Literature Review

2020 ◽  
Vol 9 (2) ◽  
pp. 1422-1433
Author(s):  
Siti Nadirah ◽  
Donny Kristanto Mulyantoro ◽  
Sri Wahyuni
Keyword(s):  
Breast Cancer ◽  
Ulcerative Colitis ◽  
Metabolic Syndrome ◽  
Curcuma Longa ◽  
Developed Countries ◽  
Hemodialysis Patients ◽  
Alanine Transaminase ◽  
Syndrome Patient ◽  
Metabolic Syndrome Patient ◽  
The Government

According to WHO, 30% of the world's population is anemic, 27% of anemia occurs in developing countries and 6% occurs in developed countries. The handling of anemia by the government has not been maximized so that companion therapy is needed. Objective: To see the potential of turmeric (curcuma longa) to increase hemoglobin. Methods: Search methods from Scopus, Pubmed, Elsevier, Willy and Google Scholar. Published 2010 2020. RCT research with prism technique. Analysis of 25 articles related to blood loss diseases. 2 articles on hemodialysis patients, 7 articles on thalassemia patients, 3 NAFLD patients, 4 ulcerative colitis patients, 1 prehypertension patient, 3 diabetes patients, 1 metabolic syndrome patient, 1 alanine transaminase elevated patient, 2 arthritis patients and 1 breast cancer patient. There are only 3 articles that show an increase in Hb levels, so it can be concluded that curcuma longa is not effective in increasing hemoglobin levels.

scholarly journals Implant Treatment with 12-Year Follow-Up in a Patient with Severe Chronic Periodontitis: A Case Report and Literature Review

2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Keisuke Seki ◽  
Yoshiyuki Hagiwara
Keyword(s):  
Periodontal Disease ◽  
Chronic Periodontitis ◽  
Case Reports ◽  
English Literature ◽  
Supportive Therapy ◽  
Periodontal Treatment ◽  
Periodontal Tissues ◽  
Severe Periodontitis ◽  
And Control ◽  
Implant Treatment

Tooth loss among adults is associated with progressive periodontitis. Implant prosthetic treatment has long been utilized in periodontal patients. Even when the implants are applied, ongoing management of periodontal disease and control of inflammation is necessary to maintain a healthy oral cavity. Lack of appropriate periodontal treatment can result in recurrence of periodontal disease during a maintenance period; loss of the supportive capacity of the periodontal tissues will increase the susceptibility of residual teeth to traumatic force. For this reason, it is worthwhile to improve oral function by applying implants as a fixed device. Here, we report that implant treatment in a patient with generalized severe chronic periodontitis helped maintain the periodontal and peri-implant tissue for a long term. We propose that initial periodontal treatment and ongoing supportive therapy can help maintain implants in patients with severe periodontitis. In addition, we reviewed case reports in the English literature so far.

Sign in / Sign up

Export Citation Format

Share Document